The triglyceride-glucose index might be a better indicator for predicting poor cardiovascular outcomes in chronic coronary syndrome

Back

ESC Professional Premium Access

The triglyceride-glucose index might be a better indicator for predicting poor cardiovascular outcomes in chronic coronary syndrome

Session: Diabetes and stable coronary artery disease

Topic: Prevention

Speaker: Doctor D. Inan (Istanbul, TR)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Duygu Inan

Basaksehir Çam ve Sakura Sehir HastanesiBasaksehir Cam ve Sakura Sehir Hastanesi, Istanbul (Türkiye)

1 follower

6 more presentations in this session

Does prediabetes diagnosed by hemoglobinA1c or oral glucose tolerance test predict coronary artery disease in patients suspected of chronic coronary syndrome?

Speaker: Doctor K. Overgaard (Svendborg, DK)

Real-life use of novel glucose lowering agents after acute myocardial infarction and stable coronary artery disease in patients with diabetes - experience from national use in the SWEDEHEART-registry

Speaker: Doctor V. Ritsinger (Stockholm, SE)

Vessel-oriented cardiovascular events in patients with diabetes undergoing intracoronary physiology-guided revascularization

Speaker: Doctor S. Sgreva (Verona, IT)

Synergistic adverse impact of diabetes and chronic kidney disease on cardiovascular mortality in patients underwent percutaneous coronary intervention

Speaker: Doctor S. Moriya (Tokyo, JP)

Diabetes mellitus and response to IL-1 blockade with Anakinra after ST-elevation myocardial infarction: a pooled analysis of the VCU-ART studies

Speaker: Doctor F. Moroni (Charlottesville, US) Doctor A. Abbate (Charlottesville, US)

Access the full session

Diabetes and stable coronary artery disease

Speakers: Doctor D. Inan, Doctor K. Overgaard, Doctor V. Ritsinger, Doctor S. Sgreva, Doctor S. Moriya...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

The triglyceride-glucose index might be a better indicator for predicting poor cardiovascular outcomes in chronic coronary syndrome

About the speaker

Doctor Duygu Inan

6 more presentations in this session

Does prediabetes diagnosed by hemoglobinA1c or oral glucose tolerance test predict coronary artery disease in patients suspected of chronic coronary syndrome?

Real-life use of novel glucose lowering agents after acute myocardial infarction and stable coronary artery disease in patients with diabetes - experience from national use in the SWEDEHEART-registry

Vessel-oriented cardiovascular events in patients with diabetes undergoing intracoronary physiology-guided revascularization

Synergistic adverse impact of diabetes and chronic kidney disease on cardiovascular mortality in patients underwent percutaneous coronary intervention

Diabetes mellitus and response to IL-1 blockade with Anakinra after ST-elevation myocardial infarction: a pooled analysis of the VCU-ART studies

Access the full session

Diabetes and stable coronary artery disease

About the event

ESC Congress 2023

ESC 365 is supported by